Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › botulinum toxin A

botulinum toxin A

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of botulinum toxin A

14 trials tracked of botulinum toxin A: 6 in phase 3 or 4 and 3 with published results. The most-cited published study has 8 citations.

14Trials tracked
6Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 2 Phase 3 4 Phase 2 4 Other / NA 4
  1. Phase 3 Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII) Completed · 8 cited
  2. Phase 3 Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I Completed · 8 cited
  3. Phase 3 Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II Completed · 8 cited
  4. Phase 4 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. Completed
  5. Phase 4 Botox for Cervical Dystonia Following EMG Mapping Completed
  6. Phase 3 Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face Completed
Show 8 more trials
  1. Phase 2 Effect of Botulinum Toxin A on Detrusor Overactivity and Renal Function in Chronic Spinal Cord Injured Patients Completed
  2. Phase 2 Safety and Efficacy of Botulinum Toxin A Injection in Patients With Painful Artificial Knee Arthroplasty (TKA) Completed
  3. Phase 2 Botulin-A Toxin Instillations and Overactive Bladder Completed
  4. Phase 2 Botulinum Toxin to Treat Restless Legs Syndrome Completed
  5. N/A HIV Posterior Cheek Enlargement Completed
  6. N/A Botulinum Toxin in the Treatment of Raynaud's Completed
  7. N/A Placebo Controlled Trial of Botulinum Toxin for Gastroparesis Completed
  8. N/A Subcutaneous Botulinum Toxin for Cutaneous Allodynia Completed

Showing the 14 most-cited and recently-updated of 14 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Botulinum toxin type A improves nasal symptoms in refractory allergic rhinitis with SMD -2.07 at 4 weeks
Allergy & Immunology Meta-analysis
Botulinum toxin type A improves nasal symptoms in refractory allergic rhinitis with SMD -2.07 at 4 weeks Botox helps stubborn nasal allergies, review finds
This meta-analysis of 187 patients with refractory allergic rhinitis found that botulinum toxin type A significantly improved total nasal sy…
For people with nasal allergies that won't quit, a review suggests Botox shots may ease symptoms as well as standard steroid injections or p…
Jun 1, 2026
BoNTA injection reduces axillary sweat in Chinese patients with primary hyperhidrosis
Drug Pipeline RCT
BoNTA injection reduces axillary sweat in Chinese patients with primary hyperhidrosis One Shot Stops Excessive Underarm Sweating for Months, Study Finds
This Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 344 Chinese patients with primary axillary hyperhidrosis fo…
A single Botox shot safely cuts underarm sweat by more than half for up to four months in people with excessive sweating.
Apr 18, 2026